Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID02910323

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia

Led by The University of Texas Health Science Center, Houston · Updated on 2026-02-18

1500

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are conducting a national, prospective, multicenter observational study at the Will Erwin Headache Research Center focused on patients with Cluster Headache and Trigeminal Neuralgia. This study also includes similar conditions such as other trigeminal autonomic cephalalgias (TACs) like paroxysmal hemicrania, SUNCT, SUNA, and hemicrania continua. The goal is to create a detailed registry that categorizes patients by condition type, severity, symptoms, and related medical or psychological issues including depression and disability. Participants include patients diagnosed with these headache disorders as well as healthy volunteer controls and family members, who may be enrolled to help identify genetic mutations. Each enrolled participant undergoes comprehensive evaluations including genomic and epigenomic studies, collection of past medical history, imaging reports, and physical exams. This registry aims to support matching patients with appropriate interventional clinical trials in the future. During the study, participants will be assessed with several scales including the HIT-6 for headache impact, the morningness-eveningness scale, and the GAD-7 for anxiety, all over an average of five years. Genetic and molecular biomarkers will also be collected and monitored throughout this period. This long-term observational study continues through its completion, providing ongoing data on the studied conditions and patient characteristics.

CONDITIONS

Brief Title

The Will Erwin Headache Research Center - Cluster Headache Study

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of trigeminal autonomic cephalalgia or trigeminal neuralgia as defined by the International Headache Classification, including various episodic and chronic forms
  • Ability to provide HIPAA authorization to share prior medical records and imaging
  • Healthy volunteers aged 18 or older willing to consent
Not Eligible

You will not qualify if you...

  • Life expectancy less than 1 year or other conditions preventing proper diagnosis
  • Active drug or alcohol use or dependence interfering with study adherence
  • Inability or unwillingness to provide informed consent or have a legal guardian provide it

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Initial assessment period

Participants undergo detailed evaluations including genomic and epigenomic studies, past medical history review, imaging reports, and physical exams to classify their condition.

1 to 2 visits depending on assessments

Long-term Monitoring

Duration - Approximately 5 years

Participants are followed over time with assessments using various scales and biomarker measurements to observe their condition.

Periodic visits for assessments throughout the study duration

Trial Site Locations

Total: 1 location

1

The University of Texas Health Science Center at Houston

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

R

Rebecca Martinez, RN

M

Mark J Burish, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Randomized, Sham-Controlled, Double-Blinded Trial of Percu...

Trigeminal Neuralgia

Actively Recruiting

1 location

Assessment of Nerve Involvement by MRI Using Diffusion Tenso...

Trigeminal Neuralgia

Actively Recruiting

1 location

Botulinum Toxin Type A Blockade of the Sphenopalatine Gangli...

Cluster Headache

Actively Recruiting

5 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

The International Classification of Headache Disorders, 3rd edition (beta version).

Headache Classification Committee of the International Headache Society (IHS)

https://pubmed.ncbi.nlm.nih.gov/23771276